Amanda Wheeler

Summary

Affiliation: Griffith University
Country: Australia

Publications

  1. ncbi Access to general health care services by a New Zealand population with serious mental illness
    Amanda Wheeler
    Griffith Health Institute, School of Human Services, Griffith University, University Drive, Meadowbrook, Queensland 4131, Australia
    J Prim Health Care 6:7-16. 2014
  2. doi Pathway to clozapine use: a comparison between a patient cohort from New Zealand and a cohort from the United Kingdom
    Amanda J Wheeler
    Griffith Health Institute, Griffith University, University Drive, Brisbane, 4131, Australia
    Clin Drug Investig 34:203-11. 2014
  3. doi Using an intervention mapping framework to develop an online mental health continuing education program for pharmacy staff
    Amanda Wheeler
    Professor Mental Health, Griffith Health Institute, Griffith University Clinical Associate Professor, Faculty of Medical and Health Sciences, University of Auckland
    J Contin Educ Health Prof 33:258-66. 2013
  4. ncbi Stereotypes do not always apply: findings from a survey of the health behaviours of mental health consumers compared with the general population in New Zealand
    Amanda J Wheeler
    Population and Social Health Research Program, Griffith Health Institute, Griffith University, Brisbane 4131, Australia
    N Z Med J 126:35-46. 2013
  5. doi One-year treatment continuation in patients prescribed risperidone long-acting injection in New Zealand: a retrospective study
    Amanda Wheeler
    Clinical Research and Resource Centre, Mental Health and Addiction Services, Waitemata District Health Board, New Zealand
    Clin Schizophr Relat Psychoses 6:61-8. 2012
  6. pmc A qualitative investigation into key cultural factors that support abstinence or responsible drinking amongst some Pacific youth living in New Zealand
    Tamasailau Suaalii-Sauni
    Vaaomanu Pasifika Unit, Victoria University of Wellington, Wellington, New Zealand
    Harm Reduct J 9:36. 2012
  7. doi Impact of audit and feedback on antipsychotic prescribing in schizophrenia
    Amanda Wheeler
    Clinical Research and Resource Centre, Mental Health and Addiction Services, Waitemata District Health Board, Auckland, New Zealand
    J Eval Clin Pract 15:441-50. 2009
  8. doi Clinician experiences of employing the AmpliChip® CYP450 test in routine psychiatric practice
    Lucy Dunbar
    Clinical Research and Resource Centre, Waitemata District Health Board, Auckland, New Zealand
    J Psychopharmacol 26:390-7. 2012
  9. doi Ethnic comparisons of antipsychotic use in schizophrenia
    Amanda Wheeler
    Clinical Research and Resource Centre, Snelgar Building, Waitakere Hospital, Waitakere, Auckland, New Zealand
    Aust N Z J Psychiatry 42:863-73. 2008
  10. ncbi Five-year follow-up of an acute psychiatric admission cohort in Auckland, New Zealand
    Amanda Wheeler
    Clinical Research and Resource Centre, Mental Health and Addiction Services, Waitemata District Health Board, Auckland, New Zealand
    N Z Med J 124:30-8. 2011

Collaborators

Detail Information

Publications33

  1. ncbi Access to general health care services by a New Zealand population with serious mental illness
    Amanda Wheeler
    Griffith Health Institute, School of Human Services, Griffith University, University Drive, Meadowbrook, Queensland 4131, Australia
    J Prim Health Care 6:7-16. 2014
    ..Literature suggests that good quality health care access can have a positive impact on the health of people with serious mental illness (SMI), but literature relating to patterns of access by this group is equivocal...
  2. doi Pathway to clozapine use: a comparison between a patient cohort from New Zealand and a cohort from the United Kingdom
    Amanda J Wheeler
    Griffith Health Institute, Griffith University, University Drive, Brisbane, 4131, Australia
    Clin Drug Investig 34:203-11. 2014
    ..This retrospective cross-sectional study compared the prescribing of clozapine in two adult cohorts under the care of large public mental health services in Auckland (New Zealand) and Birmingham (United Kingdom) on 31 March 2007...
  3. doi Using an intervention mapping framework to develop an online mental health continuing education program for pharmacy staff
    Amanda Wheeler
    Professor Mental Health, Griffith Health Institute, Griffith University Clinical Associate Professor, Faculty of Medical and Health Sciences, University of Auckland
    J Contin Educ Health Prof 33:258-66. 2013
    ..This article presents the systematic planning and development process and content of an education and training program for community pharmacy staff, using a program planning approach called intervention mapping...
  4. ncbi Stereotypes do not always apply: findings from a survey of the health behaviours of mental health consumers compared with the general population in New Zealand
    Amanda J Wheeler
    Population and Social Health Research Program, Griffith Health Institute, Griffith University, Brisbane 4131, Australia
    N Z Med J 126:35-46. 2013
    ..Our study sought to investigate the health behaviours of mental health consumers in New Zealand, as we hoped that by clearly describing this group more targeted healthcare could be provided...
  5. doi One-year treatment continuation in patients prescribed risperidone long-acting injection in New Zealand: a retrospective study
    Amanda Wheeler
    Clinical Research and Resource Centre, Mental Health and Addiction Services, Waitemata District Health Board, New Zealand
    Clin Schizophr Relat Psychoses 6:61-8. 2012
    ..Risperidone long-acting injection (RLAI) has shown low discontinuation and good tolerability in long-term clinical trials. This retrospective study investigated RLAI continuation in a naturalistic clinical setting in New Zealand...
  6. pmc A qualitative investigation into key cultural factors that support abstinence or responsible drinking amongst some Pacific youth living in New Zealand
    Tamasailau Suaalii-Sauni
    Vaaomanu Pasifika Unit, Victoria University of Wellington, Wellington, New Zealand
    Harm Reduct J 9:36. 2012
    ..abstract:..
  7. doi Impact of audit and feedback on antipsychotic prescribing in schizophrenia
    Amanda Wheeler
    Clinical Research and Resource Centre, Mental Health and Addiction Services, Waitemata District Health Board, Auckland, New Zealand
    J Eval Clin Pract 15:441-50. 2009
    ..To examine the impact of audit and feedback on antipsychotic prescribing for schizophrenia outpatients over 4.5 years...
  8. doi Clinician experiences of employing the AmpliChip® CYP450 test in routine psychiatric practice
    Lucy Dunbar
    Clinical Research and Resource Centre, Waitemata District Health Board, Auckland, New Zealand
    J Psychopharmacol 26:390-7. 2012
    ..These findings indicate that psychiatric clinicians are receptive to employing this test as a clinical support tool if its implementation is carefully considered and economically justifiable...
  9. doi Ethnic comparisons of antipsychotic use in schizophrenia
    Amanda Wheeler
    Clinical Research and Resource Centre, Snelgar Building, Waitakere Hospital, Waitakere, Auckland, New Zealand
    Aust N Z J Psychiatry 42:863-73. 2008
    ..The aim of the present study was to compare ethnic groups for antipsychotic prescribing in schizophrenia over 4.5 years...
  10. ncbi Five-year follow-up of an acute psychiatric admission cohort in Auckland, New Zealand
    Amanda Wheeler
    Clinical Research and Resource Centre, Mental Health and Addiction Services, Waitemata District Health Board, Auckland, New Zealand
    N Z Med J 124:30-8. 2011
    ..This paper describes a follow-up of acute psychiatric hospital contact in Auckland, New Zealand for an admission cohort in the 5-years past an index admission (published in the NZMJ in 2005)...
  11. doi Collaborative prescribing: a qualitative exploration of a role for pharmacists in mental health
    Amanda Wheeler
    School of Human Services, Griffith Health, Griffith University, Australia
    Res Social Adm Pharm 8:179-92. 2012
    ..Collaborative prescribing has been proposed as an extension of practice for advanced pharmacist practitioners. A lack of research investigating how pharmacists might be most effective as prescribers in mental health was identified...
  12. ncbi The CYP2D6 metaboliser status of patients prescribed risperidone for the treatment of psychosis
    Lucy Dunbar
    Clinical Research and Resource Centre, Waitemata District Health Board, Auckland, New Zealand
    N Z Med J 122:29-34. 2009
    ..To identify the distribution of CYP2D6 metaboliser status in patients who were being prescribed risperidone for the treatment of psychosis in a New Zealand-based clinical population...
  13. ncbi Atypical antipsychotic use for adult outpatients in New Zealand's Auckland and Northland regions
    Amanda Wheeler
    Clinical Research and Resource Centre, Waitemata District Health Board, PO Box 44055, Pt Chevalier, Auckland 1246
    N Z Med J 119:U2055. 2006
    ..To outline the prescribing patterns of atypical antipsychotics for adult mental health outpatients in Auckland and Northland in 2004...
  14. doi Extended-release methylphenidate for treatment of amphetamine/methamphetamine dependence: a randomized, double-blind, placebo-controlled trial
    S Wayne Miles
    Waitemata District Health Board, Auckland, New Zealand
    Addiction 108:1279-86. 2013
    ..To assess the efficacy of methylphenidate as a substitution therapy for amphetamine/methamphetamine dependence in Finland and New Zealand...
  15. ncbi Exploration of Pacific perspectives of Pacific models of mental health service delivery in New Zealand
    Tamasailau Suaalii-Sauni
    Clinical Research and Resource Centre, University of Auckland, Auckland, New Zealand
    Pac Health Dialog 15:18-27. 2009
    ....
  16. doi Explicit versus implicit review to explore combination antipsychotic prescribing
    Amanda Wheeler
    Clinical Research and Resource Centre, Mental Health and Addiction Services, Waitakere Hospital, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand
    J Eval Clin Pract 15:685-91. 2009
    ....
  17. doi Barriers and solutions to implementing metabolic risk assessment in a secondary mental health service
    Lucy Dunbar
    Clinical Research and Resource Centre, Mental Health and Addictions, Waitemata District Health Board, Auckland, New Zealand
    Australas Psychiatry 18:322-5. 2010
    ..The aim of this study is to understand the barriers and resulting solutions encountered by mental health service staff during the implementation of a metabolic risk assessment programme...
  18. ncbi Cardiovascular risk assessment and management in mental health clients: perceptions of mental health and general practitioners in New Zealand
    Amanda Wheeler
    Clinical Research and Resource Centre, Waitemata District Health Board, Auckland, New Zealand
    J Prim Health Care 1:11-9. 2009
    ..This study explores health practitioners' knowledge, attitudes, barriers/solutions towards cardiovascular risk assessment and management in mental health patients...
  19. doi Mood stabilizer loading versus titration in acute mania: audit of clinical practice
    Amanda Wheeler
    Clinical Research and Resource Centre, Waitakere Hospital, Auckland, New Zealand
    Aust N Z J Psychiatry 42:955-62. 2008
    ..The aim of the present study was to investigate whether the use of a loading strategy with lithium or valproate followed recommended practice and second, whether this had any impact on indicators of outcome in acutely manic inpatients...
  20. doi Towards quality Pacific services: the development of a service self-evaluation tool for Pacific addiction services in New Zealand
    Kathleen S Samu
    Clinical Research and Resource Centre, Waitemata District Health Board, Auckland, New Zealand
    J Eval Clin Pract 17:1036-44. 2011
    ..To describe the development and use of a quality improvement service self-evaluation tool within Pacific addiction services in New Zealand...
  21. doi Implementing metabolic risk assessment in a secondary care mental health service
    Lucy Dunbar
    Clinical Research and Resource Centre, Mental Health and Addictions, Waitemata District Health Board, Auckland, New Zealand
    Australas Psychiatry 18:318-21. 2010
    ..The aim of this study was to describe a metabolic risk assessment programme that was established by community mental health teams working within one locality of a District Health Board in Auckland...
  22. ncbi Sociodemographic, functional and clinical correlates in outpatients with schizophrenia: comparison with affective disorders
    Amanda Wheeler
    Clinical Research and Resource Centre, Snelgar Building, Waitakere Hospital, Auckland, Waitakere, New Zealand
    Aust N Z J Psychiatry 41:809-18. 2007
    ....
  23. doi Antidepressant dispensing trends in New Zealand between 2004 and 2007
    Daniel Exeter
    Section of Epidemiology and Biostatistics, School of Population Health, University of Auckland, Wellesley Street, Auckland 1142, New Zealand
    Aust N Z J Psychiatry 43:1131-40. 2009
    ..The aim of the present study was to explore antidepressant dispensing trends in New Zealand over a 3 year period (2004-2007) with a focus on trends by age, gender, ethnicity, District Health Board and type of antidepressant...
  24. ncbi Pacific healthcare workers and their treatment interventions for Pacific clients with alcohol and drug issues in New Zealand
    Gail Robinson
    Clinical Research and Resource Centre, Waitemata District Health Board and Department of Social and Community Health, University of Auckland, Auckland
    N Z Med J 119:U1809. 2006
    ..To provide an overview of the treatment interventions and practices of Pacific alcohol and other drugs (AOD) services in New Zealand...
  25. ncbi Initiation into methamphetamine use: qualitative findings from an exploration of first time use among a group of New Zealand users
    Janie Sheridan
    School of Pharmacy, University of Auckland, New Zealand
    J Psychoactive Drugs 41:11-7. 2009
    ..Several reported risk-taking behaviors on the first occasion of use. The findings have important implications for potential interventions and harm reduction strategies at first use...
  26. ncbi The substances and choices scale (SACS)--the development and testing of a new alcohol and other drug screening and outcome measurement instrument for young people
    Grant Christie
    Community Alcohol and Drug Youth Service, Waitemata District Health Board, Auckland, New Zealand
    Addiction 102:1390-8. 2007
    ..To describe the development and evaluation of the Substances and Choices Scale (SACS), an adolescent alcohol and other drug (AOD) self-report instrument designed in a similar format to the Strengths and Difficulties Questionnaire (SDQ)...
  27. doi Determining what practising clinicians believe about long-acting injectable antipsychotic medication
    S Wayne Miles
    Knowledge Centre, Waitemata District Health Board and Department of Psychological Medicine, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand
    Int J Psychiatry Clin Pract 15:135-44. 2011
    ..To explore the factors that influence clinician prescribing choice when using depot anti-psychotics...
  28. ncbi Trends in antipsychotic prescribing in schizophrenia in Auckland
    Amanda Wheeler
    Clinical Research and Resource Centre, Mental Health Services and Community Alcohol and Drug Services, Waitemata District Health Board, Auckland, New Zealand
    Australas Psychiatry 14:169-74. 2006
    ..This study describes antipsychotic prescribing practices for outpatients with schizophrenia over a 3 year period in two large mental health catchment areas of Auckland...
  29. doi New Zealand community pharmacists' views of their roles in meeting medicine-related needs for people with mental illness
    Keith Crump
    Waitemata District Health Board, Private Bag 93115, Henderson Auckland, New Zealand
    Res Social Adm Pharm 7:122-33. 2011
    ..Several roles have been identified for community pharmacists in providing care to people with mental illness; however, the specifics of these roles have not been studied in New Zealand...
  30. ncbi Sedative-hypnotic treatment in an acute psychiatric setting: comparison with best practice guidance
    Amanda Wheeler
    Clinical Research and Resource Centre, Waitemata District Health Board, Private Bag 93115, Henderson, Auckland, New Zealand
    Pharm World Sci 29:603-10. 2007
    ..The aim of this study was to review treatment patterns of sedative-hypnotic agents within an acute adult inpatient psychiatric service, compare prescribing with best-practice recommendations for use and explore potential interventions...
  31. doi Evaluation of online training for the provision of opioid substitution treatment by community pharmacists in New Zealand
    Carina Walters
    Community Alcohol and Drug Services, Waitemata District Health Board, Auckland, New Zealand
    Drug Alcohol Rev 31:903-10. 2012
    ..The evaluation explored participants' attitudes, skills and knowledge both pre- and post-training in OST...
  32. ncbi Admissions to acute psychiatric inpatient services in Auckland, New Zealand: a demographic and diagnostic review
    Amanda Wheeler
    Clinical Research and Resource Centre, Mental Health Services and Community Alcohol and Drug Services, Waitemata District Health Board, Auckland, New Zealand
    N Z Med J 118:U1752. 2005
    ..This paper describes demographic and diagnostic data for people admitted to three psychiatric units in Auckland, New Zealand over the year 2000...
  33. doi Review of community pharmacy staff educational needs for supporting mental health consumers and carers
    Amary Mey
    School of Pharmacy, Griffith University, Gold Coast, 4222, Australia
    Community Ment Health J 50:59-67. 2014
    ..No studies assessed the training needs of pharmacy support staff. A systematic analysis of pharmacy staff learning needs is warranted. ..